Escitalopram (Citalop S (5 mg)) is an antidepressant of the selective serotonin reuptake inhibitor (SSRI) class, prescribed for major depressive disorder, generalized ...

A 15-year-old boy with a DSM-IV-TR diagnosis of MD reported feeling "uncomfortable, and miserable" and needing "to move" daily, after being on fluoxetine 20 mg/day for 3 weeks. He had no baseline ...

Escitalopram is indicated for the treatment of major depressive disorder. This tentative approval is for the generic bioequivalent product to Lexapro (R), which is offered by Forest Laboratories, Inc.

WASHINGTON The FDA has granted tentative approval for Caraco’s abbreviated new drug application for escitalopram oxalate tablets (escitalopram), 5 mg, 10 mg and 20 mg. Escitalopram is indicated for ...

Please provide your email address to receive an email when new articles are posted on . Patients with coronary heart disease reported reduced anxiety and depression symptoms when taking escitalopram ...

From clinical studies it is known that recurrent depressive episodes associate with a reduced hippocampal volume. Conversely, preclinical studies have shown that chronic antidepressant treatment ...

NEW YORK, March 20, 2009 /PRNewswire-FirstCall/ -- Forest Laboratories, Inc. (NYSE: FRX) today announced that the U.S. Food and Drug Administration (FDA) has approved ...

Oral- DepressionObsessive compulsive disorder(persistent obsessions or compulsions), AnxietyPanic disorder(significant behavioral change)- Adult: 10 mg once daily ...

A 17-year-old girl was successfully treated for DSM-IV-TR MD for approximately 2.5 years on increasing doses of sertraline. The patient initially had a 4-month remission of MD on 75 mg of sertraline.